ClinicalTrials.gg

Daiichi Sankyo clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 498 studies whose lead sponsor is Daiichi Sankyo or one of 14 companies grouped under it. 37 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 16 registry names, not the registry’s. See them and correct one ↓

Compare Daiichi Sankyo with Merck and Fosun Pharma →

Pipeline: 20 programs

Each counted once: 20 with a study Daiichi Sankyo leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 5 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Daiichi Sankyo’s own registered studies; Daiichi Sankyo’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

4 of Daiichi Sankyo’s programs have a dated deal behind them: 4 developed with a partner. Each from the companies’ own releases and filings, linked; the registry does not record them.

Developed with a partner 4

What it is testing

The drugs Daiichi Sankyo’s studies test, most open studies first — 86 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 86; every drug is on its own page, and each page lists its sponsors.

Coming up

11 of Daiichi Sankyo’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. 1J’27
  4. 1F
  5. M
  6. 1A
  7. 1M
  8. J
  9. 4J
  10. A
  11. S
  12. 1O
  13. N

All 11

Show 6 more

Add all 11 to your calendar (.ics) → With an account.

All 498 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now377%Recruiting 35 · Not yet recruiting 2
  • Under way, not recruiting306%
  • Completed37074%
  • Stopped early5511%Terminated 42 · Withdrawn 13
  • Status unknown or other61%No longer available 3 · Available 2 · Approved for marketing 1

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 3316
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 826

By the year each study started; 95 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Daiichi Sankyo.

  • Daiichi Sankyo
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    322 studies
  • Daiichi Sankyo Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    73 studies
  • American Regent, Inc.
    Acquired — became part of Daiichi Sankyo, Sep 28, 2005 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    53 studies →
  • Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    18 studies →
  • Sankyo Pharma Gmbh
    Acquired — became part of Daiichi Sankyo, Sep 28, 2005 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • Plexxikon
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • Daiichi Pharmaceuticals
    Acquired — became part of Daiichi Sankyo, Sep 28, 2005 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Daiichi Sankyo UK Ltd, a Daiichi Sankyo Company
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Daiichi Sankyo France
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • U3 Pharma GmbH
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo Company
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Daiichi Sankyo Brasil Farmacêutica LTDA
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Daiichi Sankyo Turkey, a Daiichi Sankyo Company
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Daiichi Sankyo leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 498. Browse all 498 →